Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017

世界のアフェレーシス市場(治療&ドナーアフェレーシス/血液成分採取)

◆タイトル:Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017
◆商品コード:MD 1407
◆調査・発行会社:MarketsandMarkets
◆発行日:2013年1月
◆ページ数:195
◆レポート形式:pdf / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single userUSD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User(~5名まで)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate licence(社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"世界のアフェレーシス市場(治療&ドナーアフェレーシス/血液成分採取)"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場概観、市場の機会と課題、市場の動態、技術別分析、製品別分析、用途別分析、地域別分析、市場規模及び予測、競争状況、市場シェア分析、主要企業(ベンダー)分析等の情報をお届けいたします。

Apheresis is a process in which blood of a donor/patient is passed through a medical device, which separates one or more components of blood and returns the remaining with or without extracorporeal treatment or replacement of separated component.

Apheresis involves devices and disposables that leverage centrifugation and membrane separation/filtration technologies to separate blood components. Apheresis applications market studied in this report is segmented as plasmapheresis, plateletapheresis, erythrocytapheresis, leukapheresis, and other applications based on the various components collected in apheresis collection and therapeutic apheresis.

The apheresis market is driven by the advantages of apheresis collection over the whole blood collection, huge demand for plasma in plasma fractionation and research for new applications of therapeutic apheresis. However, the cost of capital investment involved and the challenges in recruiting donors for apheresis collection are inhibiting the growth of this market. The global apheresis market was valued at $1,140.8 million in 2012 and is expected to reach $1,922.4 million by 2017 growing at a CAGR of 11.0% from 2012 to 2017. The application of therapeutic apheresis for pediatric treatment is an uncaptured market and represents a prospective opportunity in the future.

North America holds the largest market share of close to 50%, followed by Europe in 2012. In the next five years, emerging countries are estimated to register the highest growth rate, primarily due to increasing investments and huge demand for blood components from countries like China and India with large population.

The key players in the market are Haemonetics Corporation (U.S.), FRESENIUS MEDICAL CARE (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc (Japan), and HemaCare Corporation (U.S.), with Haemonetics leading the pack.

Scope of the Report

The research report categorizes the global apheresis market into procedure, application, technology, product type and end-user. All these markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the apheresis market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.

Global Apheresis Market, by Procedure:

Donor Apheresis
Therapeutic Apheresis
Neurologic Disorders
Blood Disorders (TTP, Leukemia, & Others)
Renal Disease
Metabolic Disorders
Others (Rheumatic disorders, Malaria, Hyperviscosity syndrome, & others)
Global Apheresis Market, by Application:

Plasmapheresis
Plateletpheresis
Erythrocytapheresis
Leukoreduction/leukapheresis
Others (photopheresis, lipidpheresis, and Immunoadsoption)
Global Apheresis Market, by Technology:

Centrifugation
Membrane Separation/Filtration
Global Apheresis Markets, By Product type:

Devices
Disposables
Global Apheresis Markets, By End-user:

Blood banks/Blood collection centers
Hospitals & Hospital attached blood banks
Others
Apheresis Markets, By Geography:

North America
Europe
Asia
RoW (Rest of the World)
Each section of the report also provides market trends with respect to drivers, restraints, and opportunities. The report includes 13 company profiles and its competitive landscape section sketches the strategic developments in the market.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 BLOOD SHORTAGE & BLOOD SAFETY TO INCREASE THE DEMAND FOR APHERESIS BLOOD
3.3.1.2 ADVANTAGE OF APHERESIS COLLECTION OVER WHOLE BLOOD COLLECTION TO BOOST THE GROWTH
3.3.1.3 INCREASING DEMAND FOR PLASMA DERIVED PRODUCTS TO SPUR THE APHERESIS MARKET
3.3.1.4 INCREASE IN AGING POPULATION DEMANDS GROWTH OF APHERESIS
3.3.2 RESTRAINTS
3.3.2.1 LACK OF AWARENESS & CHALLENGES IN DONOR RECRUITMENT TO RESTRICT THE GROWTH OF APHERESIS
3.3.2.2 HIGH COST OF APHERESIS PROCEDURES TO HINDER THE ACCEPTABILITY
3.3.3 OPPORTUNITIES
3.3.3.1 EXTENDING REACH OF APHERESIS
3.3.3.2 UNTAPPED PEDIATRIC SEGMENT CAN SOON GAIN IMPORTANCE IN APHERESIS
3.4 MARKET SHARE ANALYSIS
3.5 END-USER ANALYSIS

4 GLOBAL MARKET, BY PROCEDURE
4.1 INTRODUCTION
4.2 AUTOMATED/APHERESIS BLOOD COLLECTION (DONOR APHERESIS)
4.3 THERAPEUTIC APHERESIS
4.3.1 NEUROLOGIC DISORDERS
4.3.2 BLOOD DISORDERS
4.3.3 RENAL DISORDERS
4.3.4 METABOLIC DISORDERS
4.3.5 OTHER DISORDERS

5 GLOBAL MARKET, BY PRODUCT TYPE
5.1 INTRODUCTION
5.2 DEVICES
5.3 DISPOSABLES

6 GLOBAL MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 CENTRIFUGATION
6.2.1 DRIVER & RESTRAINT
6.2.1.1 ADVANTAGES OFFERED BY CENTRIFUGATION TECHNOLOGY OVER MEMBRANE SEPARATION
6.2.1.2 CENTRIFUGATION APHERESIS PROCESS IS TIME-CONSUMING
6.3 MEMBRANE SEPARATION

7 GLOBAL MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 PLASMAPHERESIS
7.2.1 DRIVERS
7.2.1.1 HUGE DEMAND FOR PLASMA FROM BIOPHARMACEUTICAL COMPANIES
7.2.1.2 NEW APPLICATIONS AND OPPORTUNITIES IN DEVELOPING COUNTRIES
7.3 PLATELETPHERESIS
7.4 ERYTHROCYTAPHERESIS
7.5 LEUKAPHERESIS
7.6 OTHERS

8 GEOGRAPHIC ANALYSIS
8.1 INTRODUCTION
8.2 NORTH AMERICA
8.3 EUROPE
8.4 ASIA
8.5 ROW (REST OF THE WORLD)

9 COMPETITIVE LANDSCAPE
9.1 INTRODUCTION
9.2 MERGERS & ACQUISITIONS
9.3 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 127
9.4 PRODUCTS LAUNCH
9.5 EXPANSIONS
9.6 OTHER DEVELOPMENTS
9.7 APPROVALS

10 COMPANY PROFILES(OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)*
10.1 ASAHI KASEI MEDICAL CO., LTD. (A SUBSIDIARY OF
10.2 B. BRAUN MELSUNGEN AG
10.3 CERUS CORPORATION
10.4 FENWAL, INC.
10.5 FRESENIUS MEDICAL CARE AG & CO. KGAA
10.6 HAEMONETICS CORPORATION
10.7 HEMACARE CORPORATION
10.8 KANEKA CORPORATION
10.9 KAWASUMI LABORATORIES, INC.
10.1 MEDICA S.P.A
10.11 NIKKISO CO., LTD.
10.12 TERUMO BCT, INC.
10.13 THERAKOS, INC.
*DETAILS ON FINANCIALS, PRODUCT & SERVICES, STRATEGY, & DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

LIST OF TABLES

TABLE 1 GLOBAL MARKET, BY PROCEDURE, 2010 - 2017 ($MILLION)
TABLE 2 PEDIATRIC TRANSFUSIONS IN U.S. BY BLOOD CENTERS AND HOSPITALS IN 2008 (THOUSANDS OF UNITS)
TABLE 3 GLOBAL MARKET, BY END-USER, 2010 - 2017 ($MILLION)
TABLE 4 BLOOD BANKS & BLOOD COLLECTION CENTERS APHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 5 HOSPITALS & HOSPITAL ATTACHED BLOOD BANKS APHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 6 OTHERS APHERESIS END-USER MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 7 GLOBAL APHERESIS (DONOR & THERAPEUTIC APHERESIS) MARKET,BY PROCEDURE, 2010 - 2017 ($MILLION)
TABLE 8 AUTOMATED BLOOD COLLECTION MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 9 TYPES OF THERAPEUTIC APHERESIS PROCEDURES
TABLE 10 THERAPEUTIC APHERESIS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 11 DISEASE/DISORDER TREATED BY THERAPEUTIC APHERESIS
TABLE 12 GLOBAL THERAPEUTIC APHERESIS MARKET, BY DISEASE,2010 - 2017 ($MILLION)
TABLE 13 NEUROLOGIC DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 14 BLOOD DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 15 BLOOD DISORDERS THERAPEUTIC APHERESIS MARKET,BY DISEASES, 2010 - 2017 ($MILLION)
TABLE 16 TTP THERAPEUTIC APHERESIS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 17 LEUKEMIA THERAPEUTIC APHERESIS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 18 OTHER BLOOD DISORDER THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 19 RENAL DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 20 METABOLIC DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 21 OTHER DISORDERS - THERAPEUTIC APHERESIS MARKET,BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 22 GLOBAL MARKET, BY PRODUCT TYPE,2010 - 2017 ($MILLION)
TABLE 23 APHERESIS DEVICES MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 24 APHERESIS DEVICES MARKET, BY APPLICATIONS,2010 - 2017 ($MILLION)
TABLE 25 APHERESIS DEVICES/SYSTEMS IN THE MARKET
TABLE 26 APHERESIS DISPOSABLES MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 27 GLOBAL APHERESIS DISPOSABLES MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 28 GLOBAL MARKET, BY TECHNOLOGY,2010 - 2017 ($MILLION)
TABLE 29 DENSITY OF BLOOD COMPONENTS (KG/L)
TABLE 30 CENTRIFUGATION TECHNOLOGY BASED APHERESIS DEVICES
TABLE 31 CENTRIFUGATION-BASED APHERESIS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 32 NORTH AMERICA: CENTRIFUGATION APHERESIS MARKET,BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 33 EUROPE: CENTRIFUGATION APHERESIS MARKET, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 34 ASIA: CENTRIFUGATION APHERESIS MARKET, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 35 ROW: CENTRIFUGATION APHERESIS MARKET, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 36 SIZE OF BLOOD COMPONENTS
TABLE 37 MEMBRANE SEPARATION APHERESIS DEVICES
TABLE 38 MEMBRANE SEPARATION-BASED APHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 39 NORTH AMERICA: MEMBRANE SEPARATION APHERESIS MARKET,BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 40 EUROPE: MEMBRANE SEPARATION APHERESIS MARKET,BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 41 ASIA: MEMBRANE SEPARATION APHERESIS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 42 ROW: MEMBRANE SEPARATION APHERESIS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 43 GLOBAL MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 44 PLASMA COLLECTION IN UNITED STATES FROM 2005 TO 2010 (THOUSAND LITERS)
TABLE 45 PLASMAPHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 46 GLOBAL PLASMAPHERESIS MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 47 PLATELETPHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 48 GLOBAL PLATELETPHERESIS MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 49 ERYTHROCYTAPHERESIS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 50 GLOBAL ERYTHROCYTAPHERESIS MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 51 LEUKAPHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 52 GLOBAL LEUKAPHERESIS MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 53 OTHER APHERESIS APPLICATION MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 54 APHERESIS MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 55 NORTH AMERICA: APHERESIS MARKET, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 56 NORTH AMERICA: MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 57 NORTH AMERICA: MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 58 NORTH AMERICA: MARKET, BY TECHNOLOGY,2010 - 2017 ($MILLION)
TABLE 59 NORTH AMERICA: MARKET, BY PRODUCT TYPE,2010 - 2017 ($MILLION)
TABLE 60 NORTH AMERICA: MARKET, BY END-USER,2010 - 2017 ($MILLION)
TABLE 61 EUROPE: APHERESIS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 62 EUROPE: MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 63 EUROPE: MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 64 EUROPE: MARKET, BY TECHNOLOGY,2010 - 2017 ($MILLION)
TABLE 65 EUROPE: MARKET, BY PRODUCT TYPE,2010 - 2017 ($MILLION)
TABLE 66 EUROPE: MARKET, BY END-USER, 2010 - 2017 ($MILLION)
TABLE 67 ASIA: APHERESIS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 68 ASIA: MARKET, BY PROCEDURE, 2010 - 2017 ($MILLION)
TABLE 69 ASIA: MARKET, BY APPLICATION, 2010 - 2017 ($MILLION)
TABLE 70 ASIA: MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
TABLE 71 ASIA: MARKET, BY PRODUCT TYPE,2010 - 2017 ($MILLION)
TABLE 72 ASIA: MARKET, BY END-USER, 2010 - 2017 ($MILLION)
TABLE 73 ROW: APHERESIS MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 74 ROW: MARKET, BY PROCEDURE, 2010 - 2017 ($MILLION)
TABLE 75 ROW: MARKET, BY APPLICATION, 2010 - 2017 ($MILLION)
TABLE 76 ROW: MARKET, BY TECHNOLOGY, 2010 - 2017 ($MILLION)
TABLE 77 ROW: MARKET, BY PRODUCT TYPE,2010 - 2017 ($MILLION)
TABLE 78 ROW: MARKET, BY END-USER, 2010 - 2017 ($MILLION)
TABLE 79 MERGERS & ACQUISITIONS, 2010 - 2012
TABLE 80 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES, 2010 - 2012
TABLE 81 PRODUCTS LAUNCH, 2010 - 2012
TABLE 82 EXPANSIONS, 2010 –2012
TABLE 83 OTHER DEVELOPMENTS, 2010 - 2012
TABLE 84 APPROVALS, 2010 - 2012
TABLE 85 ASAHI KASEI MEDICAL CO., LTD: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 86 B. BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 87 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENT,2009 - 2011 ($MILLION)
TABLE 88 B. BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 89 CERUS CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE,2009 - 2011 ($MILLION)
TABLE 90 FRESENIUS MEDICAL CARE AG: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 91 FRESENIUS MEDICAL CARE AG: TOTAL REVENUE, BY SEGMENT,2009 - 2011 ($MILLION)
TABLE 92 FRESENIUS MEDICAL CARE AG: TOTAL REVENUE, BY GEOGRAPHY, 2009 - 2011 ($MILLION)
TABLE 93 HAEMONETICS: TOTAL REVENUE AND R&D EXPENDITURE,2009 - 2011 ($MILLION)
TABLE 94 HAEMONETICS: TOTAL REVENUE, BY SEGMENT,2009 - 2011 ($MILLION)
TABLE 95 HAEMONETICS: DISPOSABLES REVENUE, BY PRODUCT TYPE,2009 - 2011 ($MILLION)
TABLE 96 HAEMONETICS: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 97 KANEKA CORPORATION: TOTAL REVENUE, BY SEGMENT,2010 - 2012 ($MILLION)
TABLE 98 KAWASUMI LABORATORIES, INC.: TOTAL REVENUE AND R&D EXPENDITURE, 2008 - 2010 ($MILLION)
TABLE 99 KAWASUMI LABORATORIES, INC.: TOTAL REVENUE, BY SEGMENT,2008 - 2010 ($MILLION)
TABLE 100 NIKKISO CO., LTD: TOTAL REVENUE AND R&D EXPENDITURE,2010 - 2012 ($MILLION)
TABLE 101 NIKKISO CO., LTD: TOTAL REVENUE, BY GEOGRAPHY,2010 - 2012 ($MILLION)


LIST OF FIGURES

FIGURE 1 GLOBAL MARKET, BY APPLICATION, 2012
FIGURE 2 BLOOD INDUSTRY VALUE CHAIN
FIGURE 3 APHERESIS MARKET SEGMENTATION
FIGURE 4 APHERESIS MARKET - DRIVERS & RESTRAINTS
FIGURE 5 GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2011
FIGURE 6 KEY GROWTH STRATEGIES, 2010 - 2012



★調査レポート[世界のアフェレーシス市場(治療&ドナーアフェレーシス/血液成分採取)] ( Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017 / MD 1407) 販売に関する免責事項
[世界のアフェレーシス市場(治療&ドナーアフェレーシス/血液成分採取)] ( Apheresis Market - (Therapeutic & Donor Apheresis/Automated Blood Component Collection), Applications (Plasmapheresis, Plateletpheresis, RBC/Erythrocytapheresis, Leukapheresis, Photopheresis), Devices & Disposables - Forecasts To 2017 / MD 1407) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆